NFL Biosciences SAS Financial Flexibility Index
NFL Biosciences SAS financial flexibility index. NFL Biosciences SAS (ALNFL) has a Financial Flexibility Index of 0.02x as of June 2023. Free cash flow of €57.51K (operating CF €57.51K minus capex €0.00) represents 0% of total liabilities (€3.67 Million). See ALNFL free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of NFL Biosciences SAS (2020–2022)
Financial flexibility index of NFL Biosciences SAS from 2020 to 2022. Historical Financial Flexibility Index trend for NFL Biosciences SAS across 3 annual periods. Explore NFL Biosciences SAS debt service capacity to assess how comfortably operating cash covers total debt obligations.
NFL Biosciences SAS Financial Flexibility Index by Year (2020–2022)
NFL Biosciences SAS financial flexibility index by year from 2020 to 2022. Year-by-year free cash flow to debt coverage for NFL Biosciences SAS. For the full cash flow conversion analysis, see NFL Biosciences SAS (ALNFL) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.07x | €104.89K | €104.89K | €1.55 Million | ▼ -69.1% |
| 2021 | 0.22x | €87.00K | €87.00K | €397.73K | ▲ +11.2% |
| 2020 | 0.20x | €83.91K | €83.91K | €426.61K | — |